Coxsackievirus B3

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 20:49, October 8, 2016 by Samsara (talk | contribs) (Fixed reference error; +stub)

In mouse models, Ampligen was found to be protective of Coxsackie B3-induced myocarditis.[1]

Selenium deficiency increases the virulence of Coxsackie B3 infections in a mouse model.[2]

Coxsackievirus B3 cleaves Mitochondrial Antiviral Signaling (MAVS) protein to inhibit type I interferon induction.[3] Conversely, upregulation of MAVS inhibits coxsackie B3 by increasing type-1 interferon production.[4]

See also[edit | edit source]

References[edit | edit source]

  1. ↑ http://www.ncbi.nlm.nih.gov/pubmed/14693549
  2. ↑ http://jn.nutrition.org/content/130/2/485S.full
  3. ↑ http://www.ncbi.nlm.nih.gov/pubmed/21436888?dopt=Abstract
  4. ↑ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546859/

mouse model The use of special strains of mice to study a human disease or condition, and how to prevent and treat it

mouse model The use of special strains of mice to study a human disease or condition, and how to prevent and treat it

Retrieved from "https://me-pedia.org/w/index.php?title=Coxsackievirus_B3&oldid=17260"